ATC Classification: A16AB04Agalsidase beta is an enzyme replacement therapy used to treat a rare genetic disorder called Fabry disease. This therapy has numerous benefits for individuals with this condition. By replacing the missing or deficient enzyme, agalsidase beta helps to decrease the accumula..